NFE2L2 and arthritic joint disease: Healy and colleagues reported that activation of Nrf2 can directly interfere with the c-Jun N-terminal kinase 2 signaling activity subsequent to negative regulation of the expression of COX-2 in vitro in arthritis (Healy et al., 2005).